Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1861, Issue 5, 2016, Pages 430-438

  Magdalon, Juliana ^a   Chimin, Patricia ^a   Belchior, Thiago ^a   Neves, Rodrigo X ^a   Vieira Lara, Marcel A ^a   Andrade, Maynara L ^a   Farias, Talita S ^a   Bolsoni Lopes, Andressa ^a   Paschoal, Vivian A ^a   Yamashita, Alex S ^a   Kowaltowski, Alicia J ^a   Festuccia, William T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adiposity; Browning; Fatty acid oxidation; Mitochondria; mTOR; UCP 1

Indexed keywords

ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN BETA; FATTY ACID; GLUCOSE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MEMBRANE PROTEIN; MESSENGER RNA; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; ADIPOQ PROTEIN, MOUSE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE; TUMOR SUPPRESSOR PROTEIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BROWN ADIPOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; ENERGY EXPENDITURE; FAT MASS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE DELETION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IN VIVO STUDY; LIPOLYSIS; MITOCHONDRION; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; SIGNAL TRANSDUCTION; VISCERAL OBESITY; 129 MOUSE; ANIMAL; BAGG ALBINO MOUSE; BROWN ADIPOSE TISSUE; C57BL MOUSE; CELL RESPIRATION; DEFICIENCY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; INTRAABDOMINAL FAT; KNOCKOUT MOUSE; LIPID DIET; LOW FAT DIET; MALE; METABOLISM; OXIDATION REDUCTION REACTION; TIME FACTOR; ULTRASTRUCTURE; WHITE ADIPOCYTE;

ADIPOCYTES, BROWN; ADIPOCYTES, WHITE; ADIPONECTIN; ADIPOSE TISSUE, BROWN; ADIPOSITY; ANIMALS; CELL RESPIRATION; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; ENERGY METABOLISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENOTYPE; GLUCOSE; INSULIN; INTRA-ABDOMINAL FAT; LIPOLYSIS; MALE; MICE, 129 STRAIN; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; MULTIPROTEIN COMPLEXES; OXIDATION-REDUCTION; PHENOTYPE; SIGNAL TRANSDUCTION; TIME FACTORS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84960193621     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.02.023     Document Type: Article

References (39)

1. M. Laplante, and D.M. Sabatini mTOR signaling at a glance J. Cell Sci. 122 2009 3589 3594
2. S.J. Ricoult, and B.D. Manning The multifaceted role of mTORC1 in the control of lipid metabolism EMBO Rep. 14 2013 242 251
3. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2012 274 293
4. S.H. Um, F. Frigerio, M. Watanabe, F. Picard, M. Joaquin, M. Sticker, S. Fumagalli, P.R. Allegrini, S.C. Kozma, J. Auwerx, and G. Thomas Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity Nature 431 2004 200 205
5. O. Le Bacquer, E. Petroulakis, S. Paglialunga, F. Poulin, D. Richard, K. Cianflone, and N. Sonenberg Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2 J. Clin. Invest. 117 2007 387 396
6. P. Polak, N. Cybulski, J.N. Feige, J. Auwerx, M.A. Ruegg, and M.N. Hall Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration Cell Metab. 8 2008 399 410
7. V.P. Houde, S. Brule, W.T. Festuccia, P.G. Blanchard, K. Bellmann, Y. Deshaies, and A. Marette Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue Diabetes 59 2010 1338 1348
8. H.J. Cho, J. Park, H.W. Lee, Y.S. Lee, and J.B. Kim Regulation of adipocyte differentiation and insulin action with rapamycin Biochem. Biophys. Res. Commun. 321 2004 942 948
9. A. Gagnon, S. Lau, and A. Sorisky Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion J. Cell. Physiol. 189 2001 14 22
10. J.E. Kim, and J. Chen Regulation of peroxisome proliferator-activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis Diabetes 53 2004 2748 2756
11. H.H. Zhang, J. Huang, K. Duvel, B. Boback, S. Wu, R.M. Squillace, C.L. Wu, and B.D. Manning Insulin stimulates adipogenesis through the akt-TSC2-mTORC1 pathway PLoS One 4 2009 e6189
12. K. Duvel, J.L. Yecies, S. Menon, P. Raman, A.I. Lipovsky, A.L. Souza, E. Triantafellow, Q. Ma, R. Gorski, S. Cleaver, M.G. Vander Heiden, J.P. MacKeigan, P.M. Finan, C.B. Clish, L.O. Murphy, and B.D. Manning Activation of a metabolic gene regulatory network downstream of mTOR complex 1 Mol. Cell 39 2010 171 183
13. M. Laplante, S. Horvat, W.T. Festuccia, K. Birsoy, Z. Prevorsek, A. Efeyan, and D.M. Sabatini DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity Cell Metab. 16 2012 202 212
14. M.S. Yoon, C. Zhang, Y. Sun, C.J. Schoenherr, and J. Chen Mechanistic target of rapamycin controls homeostasis of adipogenesis J. Lipid Res. 54 2013 2166 2173
15. T. Belchior, V.A. Paschoal, J. Magdalon, P. Chimin, T.M. Farias, A.B. Chaves-Filho, R. Gorjao, P. St-Pierre, S. Miyamoto, J.X. Kang, Y. Deshaies, A. Marette, and W. Festuccia Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPAR gamma-dependent and PPAR gamma-independent actions Mol. Nutr. Food Res. 59 2015 957 967
16. W.T. Festuccia, P.G. Blanchard, V. Turcotte, M. Laplante, M. Sariahmetoglu, D.N. Brindley, and Y. Deshaies Depot-specific effects of the PPAR{gamma} agonist rosiglitazone on adipose tissue glucose uptake and metabolism J. Lipid Res. 50 2009 1185 1194
17. W.T. Festuccia, P.G. Blanchard, D. Richard, and Y. Deshaies Basal adrenergic tone is required for maximal stimulation of rat brown adipose tissue UCP1 expression by chronic PPAR-gamma activation Am. J. Physiol. Regul. Integr. Comp. Physiol. 299 2010 R159 R167
18. E. Hutter, H. Unterluggauer, A. Garedew, P. Jansen-Durr, and E. Gnaiger High-resolution respirometry - a modern tool in aging research Exp. Gerontol. 41 2006 103 109
19. B. Chausse, M.A. Vieira-Lara, A.B. Sanchez, M.H. Medeiros, and A.J. Kowaltowski Intermittent fasting results in tissue-specific changes in bioenergetics and redox state PLoS One 10 2015 e0120413
20. M. Spinazzi, A. Casarin, V. Pertegato, L. Salviati, and C. Angelini Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells Nat. Protoc. 7 2012 1235 1246
21. E.D. Rosen, and B.M. Spiegelman What we talk about when we talk about fat Cell 156 2014 20 44
22. H.L. Kenerson, M.M. Yeh, and R.S. Yeung Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation PLoS One 6 2011 e18075
23. J.L. Yecies, H.H. Zhang, S. Menon, S. Liu, D. Yecies, A.I. Lipovsky, C. Gorgun, D.J. Kwiatkowski, G.S. Hotamisligil, C.H. Lee, and B.D. Manning Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways Cell Metab. 14 2011 21 32
24. P. Chakrabarti, T. English, J. Shi, C.M. Smas, and K.V. Kandror Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage Diabetes 59 2010 775 781
25. J.T. Cunningham, J.T. Rodgers, D.H. Arlow, F. Vazquez, V.K. Mootha, and P. Puigserver mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex Nature 450 2007 736 740
26. S.M. Schieke, D. Phillips, J.P. McCoy Jr., A.M. Aponte, R.F. Shen, R.S. Balaban, and T. Finkel The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity J. Biol. Chem. 281 2006 27643 27652
27. W. Fan, and R. Evans PPARs and ERRs: molecular mediators of mitochondrial metabolism Curr. Opin. Cell Biol. 33 2015 49 54
28. K.L. Hoehn, N. Turner, M.M. Swarbrick, D. Wilks, E. Preston, Y. Phua, H. Joshi, S.M. Furler, M. Larance, B.D. Hegarty, S.J. Leslie, R. Pickford, A.J. Hoy, E.W. Kraegen, D.E. James, and G.J. Cooney Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity Cell Metab. 11 2010 70 76
29. G. Karamanlidis, A. Karamitri, K. Docherty, D.G. Hazlerigg, and M.A. Lomax C/EBPbeta reprograms white 3T3-L1 preadipocytes to a Brown adipocyte pattern of gene expression J. Biol. Chem. 282 2007 24660 24669
30. C. Chaveroux, L.J. Eichner, C.R. Dufour, A. Shatnawi, A. Khoutorsky, G. Bourque, N. Sonenberg, and V. Giguere Molecular and genetic crosstalks between mTOR and ERRalpha are key determinants of rapamycin-induced nonalcoholic fatty liver Cell Metab. 17 2013 586 598
31. D. Debevec, M. Christian, D. Morganstein, A. Seth, B. Herzog, M. Parker, and R. White Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor alpha Mol. Endocrinol. 21 2007 1581 1592
32. X. Xiang, H. Lan, H. Tang, F. Yuan, Y. Xu, J. Zhao, Y. Li, and W. Zhang Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch Diabetes 64 2015 519 528
33. K.Y. Lee, S.J. Russell, S. Ussar, J. Boucher, C. Vernochet, M.A. Mori, G. Smyth, M. Rourk, C. Cederquist, E.D. Rosen, B.B. Kahn, and C.R. Kahn Lessons on conditional gene targeting in mouse adipose tissue Diabetes 62 2013 864 874
34. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat. Med. 7 2001 947 953
35. T.P. Combs, A.H. Berg, S. Obici, P.E. Scherer, and L. Rossetti Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 J. Clin. Invest. 108 2001 1875 1881
36. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288 1295
37. R.M. Blumer, C.P. van Roomen, A.J. Meijer, J.H. Houben-Weerts, H.P. Sauerwein, and P.F. Dubbelhuis Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes Metabolism 57 2008 1655 1662
38. M.M. Alves, G.M. Fuhler, K.C. Queiroz, J. Scholma, S. Goorden, J. Anink, C.A. Spek, M. Hoogeveen-Westerveld, M.J. Bruno, M. Nellist, Y. Elgersma, E. Aronica, and M.P. Peppelenbosch PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for tuberous sclerosis complex Sci. Rep. 5 2015 14534
39. A. Thien, M.T. Prentzell, B. Holzwarth, K. Klasener, I. Kuper, C. Boehlke, A.G. Sonntag, S. Ruf, L. Maerz, R. Nitschke, S.N. Grellscheid, M. Reth, G. Walz, R. Baumeister, E. Neumann-Haefelin, and K. Thedieck TSC1 activates TGF-beta-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition Dev. Cell 32 2015 617 630